Re. Steinpreis et al., THE EFFECTS OF THE ATYPICAL ANTIPSYCHOTIC AMPEROZIDE ON VACUOUS JAW MOVEMENTS IN RATS - A NOVEL DOSE-RESPONSE PROFILE, Psychopharmacology, 138(2), 1998, pp. 107-113
Classic neuroleptic drugs produce a syndrome of vacuous jaw movements
in rats, and this syndrome has been offered as an animal model of earl
y onset extrapyramidal side effects. The atypical antipsychotics do no
t produce elevations in vacuous jaw movements, or do so only at very h
igh doses. The purpose of the present study was to determine the impac
t of the putative antipsychotic, amperozide, on vacuous jaw movements
in rats. Groups of rats received daily injections of haloperidol (0.2,
0.4, or 0.8 mg/kg), clozapine (2.0, 4.0, 8.0 mg/kg), amperozide (2.0,
4.0, 8.0 mg/kg) or vehicle for 4 weeks. Once per week, rats were obse
rved for the presence of vacuous jaw movements. Haloperidol increased
vacuous jaw movements with increasing doses. Clozapine only produced e
levations in vacuous jaw movements at the highest dose. In contrast, i
ncreasing doses of amperozide resulted in decreasing vacuous jaw movem
ents for this portion of the dose-response curve. This is the first re
port of the effect of amperozide on vacuous jaw movements and results
are discussed in terms of a potentially unique behavioral profile with
respect to this behavior.